Literature DB >> 9009192

Crosstalk between G proteins and protein kinase C mediated by the calcium channel alpha1 subunit.

G W Zamponi1, E Bourinet, D Nelson, J Nargeot, T P Snutch.   

Abstract

The modulation of voltage-dependent Ca2+ channels at presynaptic nerve terminals is an important factor in the control of neurotransmitter release and synaptic efficacy. Some terminals contain multiple Ca2(+)-channel subtypes (N and P/Q), which are differentially regulated by G-protein activation and by protein kinase C (PKC)-dependent phosphorylation. Regulation of channel activity by crosstalk between second messenger pathways has been reported although the molecular mechanisms underlying crosstalk have not been described. Here we show that crosstalk occurs at the level of the presynaptic Ca2(+)-channel complex. The alpha1 subunit domain I-II linker, which connects the first and second transmembrane domains, contributes to the PKC-dependent upregulation of channel activity, while G-protein-dependent inhibition occurs through binding of Gbetagamma to two sites in the I-II linker. Crosstalk results from the PKC-dependent phosphorylation of one of the Gbetagamma binding sites which antagonizes Gbetagamma-induced inhibition. The results provide a mechanism for the highly regulated and dynamic control of neurotransmitter release that depends on the integration of multiple presynaptic signals.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9009192     DOI: 10.1038/385442a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  153 in total

1.  delta opioid receptor modulation of several voltage-dependent Ca(2+) currents in rat sensory neurons.

Authors:  C G Acosta; H S López
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

2.  Molecular determinants of inactivation within the I-II linker of alpha1E (CaV2.3) calcium channels.

Authors:  L Berrou; G Bernatchez; L Parent
Journal:  Biophys J       Date:  2001-01       Impact factor: 4.033

3.  Involvement of both G protein alphas and beta gamma subunits in beta-adrenergic stimulation of vascular L-type Ca(2+) channels.

Authors:  P Viard; N Macrez; C Mironneau; J Mironneau
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

4.  Allosteric modulation of Ca2+ channels by G proteins, voltage-dependent facilitation, protein kinase C, and Ca(v)beta subunits.

Authors:  S Herlitze; H Zhong; T Scheuer; W A Catterall
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

5.  Control of gating mode by a single amino acid residue in transmembrane segment IS3 of the N-type Ca2+ channel.

Authors:  H Zhong; B Li; T Scheuer; W A Catterall
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

6.  Biphasic, opposing modulation of cloned neuronal alpha1E Ca channels by distinct signaling pathways coupled to M2 muscarinic acetylcholine receptors.

Authors:  U Meza; R Bannister; K Melliti; B Adams
Journal:  J Neurosci       Date:  1999-08-15       Impact factor: 6.167

7.  Identification of residues in the N terminus of alpha1B critical for inhibition of the voltage-dependent calcium channel by Gbeta gamma.

Authors:  C Cantí; K M Page; G J Stephens; A C Dolphin
Journal:  J Neurosci       Date:  1999-08-15       Impact factor: 6.167

8.  betagamma dimers derived from Go and Gi proteins contribute different components of adrenergic inhibition of Ca2+ channels in rat sympathetic neurones.

Authors:  P Delmas; F C Abogadie; G Milligan; N J Buckley; D A Brown
Journal:  J Physiol       Date:  1999-07-01       Impact factor: 5.182

9.  Multiple G-protein betagamma combinations produce voltage-dependent inhibition of N-type calcium channels in rat superior cervical ganglion neurons.

Authors:  V Ruiz-Velasco; S R Ikeda
Journal:  J Neurosci       Date:  2000-03-15       Impact factor: 6.167

10.  Reluctant gating of single N-type calcium channels during neurotransmitter-induced inhibition in bullfrog sympathetic neurons.

Authors:  H K Lee; K S Elmslie
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.